Skip to main content
Clinical Trials/NL-OMON53824
NL-OMON53824
Recruiting
Not Applicable

Zooming in on cerebral abnormalities in severely affected COVID-19 patients: a 3T and 7T MRI study - ZoomCOVID

Medisch Universitair Ziekenhuis Maastricht0 sites105 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Medisch Universitair Ziekenhuis Maastricht
Enrollment
105
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Sponsor
Medisch Universitair Ziekenhuis Maastricht

Eligibility Criteria

Inclusion Criteria

  • COVID\-19 ICU survivors:
  • \- Proven COVID\-19 infection for which they were admitted to ICU for at least 3
  • \- Included in the MaastrICCht cohort (a large database of serial measurements
  • collected during ICU stay from patients with COVID\-19 admitted to the ICU in
  • het Maastricht University Medical Centre\+; METC 2020\-1565/3 00 523\)
  • \- Age \>\= 18 years
  • \- Informed consent
  • \- Sufficient command of the Dutch language to follow test instructions and
  • understand the information letter, informed consent, and questionnaires
  • ICU survivors:

Exclusion Criteria

  • COVID\-19 ICU survivors:
  • \- Objective cognitive impairments before the hospital admission for the
  • COVID\-19 infection
  • \- An unexpected incident leading to severe neurological damage after hospital
  • discharge (such as stroke or traumatic brain injury)
  • \- Contra\-indications for MRI scanning (e.g. metal implants, cardiac pacemaker,
  • claustrophobia, pregnancy and tattoos in the head/neck region)
  • \- Unwillingness to be informed about clinical relevant (abnormal) MRI\-findings
  • \- Physical inability to travel to one of the locations (e.g., bedridden
  • ICU survivors:

Outcomes

Primary Outcomes

Not specified

Similar Trials